KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Deferred Taxes (2017 - 2025)

Exact Sciences (EXAS) has disclosed Deferred Taxes for 8 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Deferred Taxes rose 91.36% to -$1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.5 million, a 84.74% increase, with the full-year FY2025 number at -$1.5 million, up 84.74% from a year prior.
  • Deferred Taxes was -$1.0 million for Q4 2025 at Exact Sciences, down from $501000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $1.8 million in Q1 2024 to a low of -$243.1 million in Q1 2021.
  • A 5-year average of -$13.9 million and a median of -$1.0 million in 2025 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: plummeted 9934.26% in 2021, then skyrocketed 225.88% in 2025.
  • Exact Sciences' Deferred Taxes stood at -$4.5 million in 2021, then soared by 42.62% to -$2.6 million in 2022, then surged by 73.54% to -$676000.0 in 2023, then plummeted by 1667.16% to -$11.9 million in 2024, then soared by 91.36% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Deferred Taxes are -$1.0 million (Q4 2025), $501000.0 (Q3 2025), and -$6000.0 (Q2 2025).